2021年最新SCI期刊影响因子查询系统
Cardiovascular Engineering and Technology 期刊详细信息
基本信息
期刊名称 | Cardiovascular Engineering and Technology Cardiovascular Engineering and Technology |
---|---|
期刊ISSN | 1869-408X |
期刊官方网站 | https://www.springer.com/engineering/biomedical+engineering/journal/13239 |
是否OA | 否 |
出版商 | Springer Publishing Company |
出版周期 | |
始发年份 | |
年文章数 | 54 |
最新影响因子 | 2.305(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学4区 | CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统4区 | 否 | 否 |
ENGINEERING, BIOMEDICAL 工程:生物医学4区 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 1.64 | 0.531 | 0.823 |
Engineering Biomedical Engineering |
108 / 205 | 47% |
|||
Medicine Cardiology and Cardiovascular Medicine |
135 / 322 | 57% |
补充信息
自引率 | 7.40% |
---|---|
H-index | 20 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1869-408X%5BISSN%5D |
投稿指南
期刊投稿网址 | https://www.editorialmanager.com/cvet/default.aspx |
---|---|
收稿范围 | Cell Biology and Toxicology (CBT) is an international journal focused on clinical and translational research with an emphasis on molecular and cell biology, genetic and epigenetic heterogeneity, drug discovery and development, and molecular pharmacology and toxicology. CBT has a disease-specific scope prioritizing publications on gene and protein-based regulation, intracellular signaling pathway dysfunction, cell type-specific function, and systems in biomedicine in drug discovery and development. CBT publishes original articles with outstanding, innovative and significant findings, important reviews on recent research advances and issues of high current interest, opinion articles of leading edge science, and rapid communication or reports, on molecular mechanisms and therapies in diseases. SUBJECTS COVERED: 1. Gene and protein-based regulations in diseases CBT welcomes submissions in the fields of genomics and proteomic, functional genomics and proteomics, computational biology, and gene expression and function. CBT particularly includes aspects of the multifactorial genetics and epigenetics of diseases, disease-specific biomarkers, developmental biology, systems biology and bioinformatics-based data mining approaches with translational potentials. 2. Molecular pharmacology and toxicology CBT specially focuses on drug target identification and validation, rational drug design, genetic/small molecule (high-throughput) screening, novel therapeutic approaches, combinatorial and parallel synthesis of drugs, pharmacokinetics and pharmacodynamics, pharmacogenomics and toxicogenomics. 3. Pathological mechanisms related with intracellular organelles and cells CBT publishes novel findings on membrane biology and domains, and the associated receptor and non-receptor mediated signaling and transport proteins of the cell membrane, mitochondria, the endoplasmic reticulum, Golgi apparatus, and other organelles in health and disease. On the cellular and organism level, CBT aims to understanding cancer development, maintenance and treatment resistance, immune and inflammatory cell function, neuroscience, stem cell development and differentiation, epithelial biology and endothelial barrier function. 4. Biomedical aspects of organ systems in diseases CBT primarily publishes studies on the immune system, central and autonomic nervous systems, gastrointestinal system, cardiovascular and circulatory system, endocrine system, and pulmonary system, skeletal and muscular system, and urinary system to understand deeper about pathogeneses and therapies. |
收录体裁 | |
投稿指南 | |
投稿模板 | |
参考文献格式 | |
编辑信息 |